Randomized Controlled Trial
Copyright ©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2256-2268
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2256
Table 1 Clinical and allergy characteristics of patients in the hypoallergenic population at inclusion (n = 29 patients), n (%)
Characteristicsn (%)
Age, mo8.03 (7.43)
Male16 (55.2)
Anthropometric characteristics at birth
WFA z-score, mean ± SD0.1 (1.0)
LFA z-score, mean ± SD0.2 (1.3)
HCA z-score, mean ± SD1.0 (1.0)
Gestational age, mean ± SD, wk38.5 (2.3)
Preterm6 (20.7)
Anthropometric characteristics at inclusion
WFA z-score, mean ± SD-0.3 (1.2)
LFA z-score, mean ± SD0.0 (1.4)
WFL z-score, mean ± SD-0.4 (1.0)
BMI-for-age z-score, mean ± SD-0.4 (1.0)
HCA z-score, mean ± SD0.7 (1.2)
Feeding history
Breastfeeding in the past22 (75.9)
Duration of (exclusive and/or partial) breastfeeding, mean ± SD, wk17.6 (16.2)
Duration of feeding with the formula taken before inclusion, mean ± SD, wk10.8 (13.1)
Average volume of the formula taken before inclusion, mean ± SD, mL/d655.2 (199.3)
Solid foods diversification18 (62.1)
Allergy history
At least one parent or sibling with a medically confirmed allergy14 (48.3)
Parents’ smoking habits
Past only5 (17.2)
Current11 (37.9)
Mother only4 (13.8)
Father only6 (20.7)
Both parents1 (3.4)
Age at onset of first CMA symptoms, mean ± SD, mo3.6 (4.4)
Time since beginning of the elimination diet, median (min–max; IQR), wk8.3 (2.0–125.3; 9.7)
Time elapsed between the onset of allergy symptoms and the initiation of the elimination diet, median (min – max; IQR), wk1.9 (0.1-46.0; 5.7)
Type of first CMA symptoms
Exclusively digestive10 (34.5)
Exclusively cutaneous2 (6.9)
Digestive and cutaneous3 (10.3)
Digestive symptoms and other symptoms such as crying, irritability, abdominal pain, and agitated sleep5 (17.2)
Digestive symptoms and failure to thrive6 (20.7)
Digestive, cutaneous and other symptoms such as crying, irritability, and agitated sleep3 (10.3)
Delay of first CMA symptoms
Immediate1 (3.4)
Delayed28 (96.6)
Type of food triggering the first CMA symptoms
Mother’s milk4 (13.8)
Infant formula25 (86.2)
Table 2 Characteristics of reactions (immediate and delayed) observed after cow’s milk introduction during the double-blind placebo-controlled food challenge performed before (n = 19) or after study inclusion (n = 10), n (%)
Characteristics of patients with immediate reactions (n = 5)
Types of reactions
Objective gastrointestinal complaints5 (100.0)
Severe reaction1 (20.0)
Moderate reaction1 (20.0)
Mild reaction13 (60.0)
Time of reaction after the ingestion of first CMP dose, mean ± SD, min98.0 (4.5)
Eliciting dose of CMP, mean ± SD, g2.2 (1.3)
Cumulative dose of CMP, mean ± SD, g4.7 (2.9)
Characteristics of patients with delayed reactions only (n = 24)
Types of reactions
Digestive and cutaneous symptoms22 (8.3)
Upper digestive symptoms (regurgitations and vomiting)28 (33.3)
Lower digestive symptoms (changes in stools frequency/consistency and bloody stools)29 (37.5)
Lower and upper digestive symptoms23 (12.5)
Eczema1 (4.2)
Irritability/crying31 (4.2)
Cumulative dose of CMP, mean ± SD, g3.9 (1.8)
Time of reaction after hospital discharge
Within 6 h11 (45.8)
Between 6 and 12 h5 (20.8)
> 24 h8 (33.4)
Table 3 mean ± SD anthropometric Z-scores at baseline, Day 45 and Day 90
LFA z-scoreWFL z-scoreBMI z-scoreHCA z-score
Baselinen29272728
mean ± SD0.0 (1.5)-0.4 (1.0)-0.4 (1.0)0.5 (1.2)
D45n29272728
mean ± SD0.0 (1.7)0.0 (1.1)-0.1 (1.1)0.5 (1.2)
P-values1NS0.01120.0232NS
D90n29272728
mean ± SD0.1 (1.7)0.3 (1.2)0.2 (1.2)0.6 (1.1)
P-values1NS< 0.00130.0022NS